CCGs strain to hear voice of patients

9 January 2013

CCGs understand the need to engage with patients but questions remain about their ability to translate good intentions into effective plans and to hold their nerve when unpopular decisions need taking.

These are among the findings of a new report based on interviews with 18 people from six CCGs including the clinical lead (usually the chair), accountable officer and lay board member.

Commissioned by the Department of Health for the NHS Commissioning Board, the study* found a high level of awareness and enthusiasm for the principle but underlying anxieties about PPE in practice.

The report’s authors deliberately talked to CCGs in the second and third waves of authorisation to get a picture of the average. They found most of the sample able to produce examples of engagement initiatives targeted to particular conditions (for example dementia and HIV) or around particular services (for example urgent care). They also found CCGs starting to have “productive discussions” about investment priorities and the need for service change.

These examples should not be mistaken for what the report calls an “embedded engagement culture”.  Acknowledging that CCGs are still barely formed, the report expresses concern about the “few specific examples of PPE in the authorisation process” and the lack of involvement of lay members.  Only one of the CCGs had involved a lay member in the authorisation process.

Despite signs of engagement activity, there is less evidence of shared understanding and “a lack of understanding about what it might mean to be ‘patient-focused’ or ‘patient-centred’”.

The report also raises questions about whether CCGs are engaging people at the right time. Engagement tends to be concentrated on the middle phases of the commissioning cycle (planning and service design), but should start earlier with “needs and aspirations”, the authors suggest. Similarly, patients and the public could be involved in the later procurement and monitoring phases of commissioning, allowing them to influence the choice of provider and the quality of the service.   

The report found evidence that some CCGs see potential for conflict in their roles as patient champions and effective commissioners. “Many…aim to be responsive ‘listening organisations’. This does not always sit comfortably with the need to make tough commissioning (and decommissioning) decisions.”

The report’s co-author Andrew Craig of Moore Adamson Craig Partnership, said: “These CCG leaders know that embedding engagement in everything they do is essential if they are to make commissioning decisions and service changes with broad user and carer understanding and community support. 

“They are hungry for metrics to measure the impact of their engagement efforts.  With the right support and encouragement they should quickly become local organisations that listen and engage well.”

Interviewees acknowledged concerns that patient participation groups (PPGs) were not representative of the wider population and related concerns about their ability to scale up communication to large numbers of people.  The authors concede that these groups may be the “primary building blocks” for engagement, but point out that CCGs have yet to tackle the problem of how to use PPGs as part of bigger engagement structures.

Article Type
Briefings
Leadership and engagement

Latest News

Recommended Musculoskeletal Indicator Set launched

21 July 2017

Arthritis Research UK has worked in partnership with the musculoskeletal community, as part of NHS England and the Arthritis and Musculoskeletal Alliance’s (ARMA) Musculoskeletal (MSK) programme, to create the recommended MSK Indicator Set; a standard set of indicators for musculoskeletal health systems relevant to people with MSK conditions and commissioners. The list of indicators and final report are both available to view and download. The Recommended MSK Indicator Set reflects the agreed objectives for musculoskeletal health systems and is a mixture of generic and condition-specific indicators that includes both process and outcome measures. These indicators are intended to be used for local analysis which will highlight the reasons for variation.

Read More

More clinical pharmacists set to work in GP surgeries

21 July 2017

Further applications for Clinical pharmacists in the general practice programme have been approved meaning more than 520 clinical pharmacists covering 1,791 GP sites will benefit an additional 18.5 million patients. This builds on the 494 clinical pharmacists already working across around 650 GP practices as part of a pilot scheme. Clinical pharmacists work in general practice teams to help patients manage their medication effectively. This improves the quality of care and ensures patient safety as well as freeing up time for GPs to focus on patients with the most complex health issues. Applications are considered on an on-going basis and the next deadline is 29th September 2017. More information can be found on the NHS England website.

Read More

Sustainability and transformation plans: five key questions for planners

20 July 2017

This analysis identifies five key questions to ask each STP area to assess the potential impact of each plan. The scrutiny framework this paper outlines focuses particularly on workforce planning, access to services, service quality, integration of services and numbers of beds.

Read More

NHS England annual report and accounts 2016/17

20 July 2017

NHS England has published its annual report and accounts for 2016/17, detailing the work of the organisation over the last year and outlining some of the most significant achievements and challenges.

The report sets out progress made in delivering the NHS Five Year Forward View, the 2016/17 business plan and the Government’s mandate to NHS England.

Read More

Patients to benefit from £325 million investment in NHS transformation projects

20 July 2017

Health Secretary Jeremy Hunt and NHS England boss Simon Stevens have announced £325m of capital investment for local projects that will help the NHS modernise and transform care for patients.

Hunt and Stevens gave the green light to local capital investment schemes in 15 areas of the country, with the largest sums being used for urgent care in Dorset, surgery in Greater Manchester and cancer care in Cumbria.

Patients will see this investment deliver faster diagnosis for conditions like cancer, easier access to mental health care, expansion of A&Es, shorter waits for operations and more services in GP surgeries.

Read More